Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, August 22, 2018
Nemus Bioscience announced an agreement with AMRI for the development and manufacture of Nemus’ proprietary cannabinoid-based active pharmaceutical ingredients (API).
read more
Monday, February 25, 2019
Nemus Bioscience has signed an agreement with Pharmaceuticals International Inc. (Pii), a CDMO to develop a sterile eye drop dosage formulation of NB1111 for human dosing.
read more
Monday, September 17, 2018
Nemaura Pharma has entered into a license agreement with a Global Pharma Company to develop 3 new Transdermal Patch products.
read more
Wednesday, December 27, 2023
Nectin Therapeutics Ltd. (Nectin), a biotechnology firm dedicated to developing innovative targeted immunotherapies to overcome resistance to approved immune oncology treatments, has announced significant advancements in its Phase 1 clinical trial of...
read more
Nebula Genomics has signed an agreement for EMD Serono to access genomic data on Nebula’s blockchain-based network for genomic data sharing.
read more
New Enterprise Associates, Inc. (NEA) Venture Partner Scott Gottlieb, M.D., has been nominated by President Donald J. Trump to serve as Commissioner of the U.S. Food and Drug Administration (FDA). A physician, policy expert, and champion of health ...
read more
Tuesday, October 20, 2020
NCCN Oncology Research Program announced plans to evaluate neratinib, a type of TKI that works as a dual inhibitor of the epidermal growth factor receptor 1 and HER2.
read more
Tuesday, September 01, 2020
The NCCN Oncology Research Program announced plans to develop a program to scientifically evaluate and facilitate clinical trials on the efficacy of decitabine and cedazuridine.
read more
Monday, December 04, 2017
Ncardia have entered into a global non-exclusive IP licensing agreement with Evotec.
read more
Friday, February 07, 2020
Navrogen and Levena Biopharma announced the expanded collaboration to develop ADCs targeting humoral immuno-suppressed cancers.
read more
Navin Molecular, an Indian-headquartered CDMO with small molecule development and manufacturing capabilities, announced a Rs 288 Crore (approximately US$35 million) investment to construct a 9,000-square-metre GMP manufacturing plant in Dewas, India.
read more
Wednesday, January 15, 2025
Navin Molecular, an Indian-headquartered CDMO, announced a Rs 10 Crore (approximately US$1.2 million) investment to construct a new 1,200-square-metre research and development facility at its site in Dewas, India.
read more
Navin Fluorine International Ltd (NFIL)., part of the Padmanabh Mafatlal Group, announced the new identity for its contract development and manufacturing division, Navin Molecular.
read more
Sunday, September 18, 2016
Navidea Biopharmaceuticals has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has granted a positive opinion for a new Lymphoseek® 50 microgram kit for radiopharmaceutical preparation.
read more
Tuesday, December 08, 2020
Natoli Engineering has hired Gerardo Zuniga as their new West Coast Service Technician based at their Southern California Technical Center.
read more